Jeremy M. Schefner, MD, PhD

Kemper and Ethel Marley Professor and Chair of Neurology, and senior vice president, Barrow Neurological Institute


Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)

March 17, 2021

Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.